Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis (Q34478705)

2 August 2017

Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis (English)

1 reference

2 August 2017

0 references

4

1 reference

2 August 2017

13

1 reference

2 August 2017

Susan Donath

3

0 references

Willem Albert Hanekom

10

object named as

Willem Hanekom

1 reference

2 August 2017

Kattia Camacho-Badilla

6

object named as

Kattia Camacho-Badilla

1 reference

2 August 2017

Marc Tebruegge

1

1 reference

2 August 2017

Binita Dutta

2

1 reference

2 August 2017

Benjamin Forbes

5

1 reference

2 August 2017

Vanessa Clifford

7

1 reference

2 August 2017

Christel Zufferey

8

1 reference

2 August 2017

Roy Robins-Browne

9

1 reference

2 August 2017

Stephen M Graham

11

1 reference

2 August 2017

Tom Connell

12

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 June 2015

1 reference

American Journal of Respiratory and Critical Care Medicine

2 August 2017

1 reference

2 August 2017

192

1 reference

2 August 2017

485-499

1 reference

2 August 2017

4

1 reference

Childhood pulmonary tuberculosis: old wisdom and new challenges

2 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Discordance between TSTs and IFN-gamma release assays: the role of NTM and the relevance of mycobacterial sensitins

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Specific immune-based diagnosis of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Interferon- release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Interferon-γ Release Assays for the Diagnosis of Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

The potential danger of a solely interferon-gamma release assay-based approach to testing for latent Mycobacterium tuberculosis infection in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Indeterminate interferon-gamma release assay results in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Extremes of age are associated with indeterminate QuantiFERON-TB gold assay results

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

How can immunology contribute to the control of tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Biomarkers of latent TB infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Cytokines for monitoring anti-tuberculous therapy: A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Absence of interferon-gamma release assay conversion following tuberculin skin testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Cytokine responses to quantiferon peptides in pediatric tuberculosis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Discriminating between latent and active tuberculosis with multiple biomarker responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Can interferon-gamma or interferon-gamma-induced-protein-10 differentiate tuberculosis infection and disease in children of high endemic areas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

IP-10, MCP-1, MCP-2, MCP-3, and IL-1RA hold promise as biomarkers for infection with M. tuberculosis in a whole blood based T-cell assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Potential role for IL-2 ELISpot in differentiating recent and remote infection in tuberculosis contact tracing

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Different patterns of cytokines and chemokines combined with IFN-γ production reflect Mycobacterium tuberculosis infection and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Infectious complications of tumor necrosis factor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Cytoskeletal and adhesive structural polarizations accompany IL-13-induced human macrophage fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Alternative activation of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Detection of interleukin-2 in addition to interferon-γ discriminates active tuberculosis patients, latently infected individuals, and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: A case–control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201501-0059OC

10.1164/RCCM.201501-0059OC

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference